✦ LIBER ✦

Improved antioxidant status after supplementation with N-3 fatty acids and/or antioxidants in addition to A regular diet in patients with Crohn's disease in A double blind placebo controlled study

✍ Scribed by Geerling, B.J.; van Deursen, C.; Stockbrügger, R.W.; Brummer, R-J.M.

Book ID: 123010951
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 157 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)84004-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of antioxidants/N-3 fatty aci

The effect of antioxidants/N-3 fatty acids supplementation on the plasma phospholipid fatty acid pattern and disease activity in patients with Crohn's disease in a double blind placebo controlled study

✍ Geerling, B.J.; van Houwelingen, A.C.; Stockbrügger, R.W.; brummer, R-J.M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Ciprofloxacin or metronidazole for the t

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study

✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with

Sa1198 Vitamin D Supplementation Improve

Sa1198 Vitamin D Supplementation Improves Muscle Strength, Fatigue and Quality of Life in Patients With Crohn's Disease in Remission: Results of a Randomized Double-Blind Placebo-Controlled Study

✍ Raftery, Tara C.; Healy, Martin; Cox, Gerry; McNamara, Deirdre; O'Sullivan, Mari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Randomised clinical trial: efficacy of t

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease – a double-blind, placebo-controlled study

✍ H. Miwa; K. Inoue; K. Ashida; T. Kogawa; A. Nagahara; S. Yoshida; N. Tano; Y. Ya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Bari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

493 Safety Profile and Signal of Efficac

493 Safety Profile and Signal of Efficacy of a Non-Fcr-Binding, Fully Human Anti-Cd3 Monoclonal Antibody in Patients with Moderate to Severe Crohn's Disease- Results of a Phase I/Iia, Double Blind, Placebo-Controlled, Randomized, Dose Escalation Study

✍ Christien J. van der Woude; Pieter C. Stokkers; Ad A. van Bodegraven; Gert A. Va 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB